Outcomes of Uveoscleral Outflow Enhancement in Glaucoma Patients
Description
Dr. Emily Schehlein interviews Dr. Ticiana De Francesco on the results of her case series evaluating the safety and efficacy of the scleral allograft–reinforced cyclodialysis in patients with primary open-angle glaucoma through 24 months of follow-up. From her recent Ophthalmology Science article, “Bio-interventional Uveoscleral Outflow Enhancement Surgery for Primary Open-Angle Glaucoma: 2-Year Results of Cyclodialysis with Scleral Allograft Reinforcement.”
Bio-interventional Uveoscleral Outflow Enhancement Surgery for Primary Open-Angle Glaucoma: 2-Year Results of Cyclodialysis with Scleral Allograft Reinforcement. Calvo, Ernesto et al. Ophthalmology Science, Volume 5, Issue 4.
Sign up for the next Ophthalmology Journal Virtual Club on August 27, 2025, at https://store.aao.org/ophthalmology-virtual-journal-club.html
Do you want to get the best rates for registration to the largest ophthalmology meeting in the world? Then hurry to register for AAO 2025 in Orlando to get savings with Early Registration rates through August 6. Register now at aao.org/RegNow
United States
